| __timestamp | Incyte Corporation | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 508491000 | 1256834000000 |
| Thursday, January 1, 2015 | 726779000 | 1271973000000 |
| Friday, January 1, 2016 | 1047532000 | 1173296000000 |
| Sunday, January 1, 2017 | 1456737000 | 1274610000000 |
| Monday, January 1, 2018 | 1787760000 | 1437534000000 |
| Tuesday, January 1, 2019 | 2044510000 | 2201424000000 |
| Wednesday, January 1, 2020 | 2535374000 | 2203504000000 |
| Friday, January 1, 2021 | 2835276000 | 2462160000000 |
| Saturday, January 1, 2022 | 3187638000 | 2783406000000 |
| Sunday, January 1, 2023 | 3440649000 | 2832257000000 |
| Monday, January 1, 2024 | 3929149000 | 2832257000000 |
Infusing magic into the data realm
In the ever-evolving pharmaceutical industry, understanding financial trends is crucial for investors and stakeholders. This analysis delves into the gross profit trajectories of two major players: Takeda Pharmaceutical Company Limited and Incyte Corporation, from 2014 to 2023. Over this period, Takeda's gross profit consistently dwarfed that of Incyte, reflecting its expansive market reach and diversified portfolio. In 2023, Takeda's gross profit peaked at approximately 2.83 trillion, marking a 125% increase from 2014. In contrast, Incyte's gross profit grew by an impressive 577%, reaching 3.44 billion in 2023. This stark contrast highlights Takeda's established dominance and Incyte's rapid growth trajectory. Notably, data for Incyte in 2024 is unavailable, suggesting potential volatility or reporting delays. As the pharmaceutical landscape continues to shift, these insights offer a glimpse into the strategic positioning and financial health of these industry giants.
Merck & Co., Inc. vs Incyte Corporation: A Gross Profit Performance Breakdown
Bristol-Myers Squibb Company and Takeda Pharmaceutical Company Limited: A Detailed Gross Profit Analysis
Gross Profit Comparison: Gilead Sciences, Inc. and Incyte Corporation Trends
Gross Profit Trends Compared: Takeda Pharmaceutical Company Limited vs Walgreens Boots Alliance, Inc.
Takeda Pharmaceutical Company Limited vs Grifols, S.A.: A Gross Profit Performance Breakdown
Who Generates Higher Gross Profit? Takeda Pharmaceutical Company Limited or Arrowhead Pharmaceuticals, Inc.
Takeda Pharmaceutical Company Limited vs Supernus Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Gross Profit Comparison: Takeda Pharmaceutical Company Limited and Amphastar Pharmaceuticals, Inc. Trends
Who Generates Higher Gross Profit? Biogen Inc. or Incyte Corporation
United Therapeutics Corporation and Incyte Corporation: A Detailed Gross Profit Analysis
Gross Profit Analysis: Comparing Incyte Corporation and Arrowhead Pharmaceuticals, Inc.
Incyte Corporation vs Supernus Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown